The blockade of interleukin‐33 released by hepatectomy would be a promising treatment option for cholangiocarcinoma-Reference-Cited by-同舟云学术

The blockade of interleukin‐33 released by hepatectomy would be a promising treatment option for cholangiocarcinoma

Published:2020-11-24 Issue:1 Volume:112 Page:347-358
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Nagaoka Satoshi¹,Yamada Daisaku¹^ORCID,Eguchi Hidetoshi¹^ORCID,Yokota Yuki¹,Iwagami Yoshifumi¹,Asaoka Tadafumi¹,Noda Takehiro¹^ORCID,Kawamoto Koichi¹,Gotoh Kunihito¹,Kobayashi Shogo¹,Miyoshi Eiji²,Doki Yuichiro¹,Mori Masaki¹

Affiliation:

1. Department of Gastroenterological Surgery Graduate School of Medicine Osaka University Osaka Japan

2. Department of Molecular Biochemistry and Clinical Investigation Graduate School of Medicine Osaka University Osaka Japan

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.14709

Reference55 articles.

1. Surgical treatment of intrahepatic cholangiocarcinoma in the USA

2. Impact of Classification of Hilar Cholangiocarcinomas (Klatskin Tumors) on the Incidence of Intra- and Extrahepatic Cholangiocarcinoma in the United States

3. Pathogenesis, Diagnosis, and Management of Cholangiocarcinoma

4. Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update

5. Burden of Digestive Diseases in the United States Part III: Liver, Biliary Tract, and Pancreas

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interleukin‐33 and liver natural killer cells: A novel perspective on antitumor activity in liver fibrosis;Hepatology Research;2024-08-12

2. The combination of gemcitabine plus an anti-FGFR inhibitor can have a synergistic antitumor effect on FGF-activating cholangiocarcinoma;Cancer Letters;2024-07

3. Interleukin 33 supports squamous cell carcinoma growth via a dual effect on tumour proliferation, migration and invasion, and T cell activation;Cancer Immunology, Immunotherapy;2024-04-25

4. Unveiling the power of microenvironment in liver regeneration: an in-depth overview;Frontiers in Genetics;2023-12-13

5. The association of serum IL-33/ST2 expression with hepatocellular carcinoma;BMC Cancer;2023-07-28